Characterization of operating parameters for XMuLV inactivation by low pH treatment.
To ensure the viral safety of protein therapeutics made in mammalian cells, purification processes include dedicated viral clearance steps to remove or inactivate adventitious and endogenous viruses. One such dedicated step is low pH treatment, a robust and effective method commonly used in monoclonal antibody production to inactivate enveloped viruses. To characterize the operating space for low pH viral inactivation, we performed a statistically designed experiment evaluating the effect of pH, temperature, hold duration, acid type, and buffer concentration on inactivation of the retrovirus model, XMuLV. An additional single factor experiment was performed to study the effect of protein concentration. These data were used to generate predictive models of inactivation at each time point studied, which can be used to identify conditions for robust and effective XMuLV inactivation. At pH 3.6, XMuLV inactivation was rapid, robust, and relatively unaffected by the other factors studied, providing support for this as a generic viral inactivation condition for products that can tolerate this low pH. At pH 3.7 and 3.8, other factors besides pH affected XMuLV inactivation. By understanding the impact of each factor on inactivation, the factors can be manipulated within the operating space to ensure effective inactivation while achieving desired product quality goals.
Cellular Resources, Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA, 91320.
Shivanthi
S
Chinniah
Drug Substance Development, Amgen Inc, 1201 Amgen Court West, Seattle, WA, 98119.
Peter
P
Hinckley
Just Biotherapeutics, 454 N. 34th St., Seattle, WA.
Lisa
L
Connell-Crowley
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D001709:Biotechnology; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D009052:Leukemia Virus, Murine / Q000254:growth & development* / Q000472:pathogenicity; D012190:Retroviridae / Q000187:drug effects; D013696:Temperature; D014759:Viral Envelope Proteins / Q000737:chemistry* / Q000276:immunology; D038301:Virus Inactivation
D000911:Antibodies, Monoclonal; D014759:Viral Envelope Proteins
XMuLV; downstream processing; low pH inactivation; viral clearance